US Stock MarketDetailed Quotes
CLNN Clene
- 4.0800
- -0.0900-2.16%
Close Nov 25 16:00 ET
- 4.0800
- 0.00000.00%
Post 17:20 ET
32.56MMarket Cap-771P/E (TTM)
4.5900High4.0600Low371.29KVolume4.2400Open4.1700Pre Close1.55MTurnover9.16%Turnover RatioLossP/E (Static)7.98MShares12.000052wk High-7.89P/B16.55MFloat Cap3.818152wk Low--Dividend TTM4.06MShs Float356.4000Historical High--Div YieldTTM12.71%Amplitude3.8180Historical Low4.1860Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Clene Stock Forum
Dow Jones· just
Wed, Oct 2, 2024 at 7:21 AM EDT
This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community.
LOS ANGELES, CA - (NewMediaWire) - October 2, 2024 - Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal functio...
Clene Announces New CNM-Au8® Biomarker and Clinical Efficacy Data Submitted to FDA In Support of Treatment For ALS
Clene Inc. (Nasdaq: CLNN) has submitted new CNM-Au8 biomarker and clinical efficacy data to the FDA for ALS treatment. Key findings include:
1. CNM-Au8 NfL Responders showed significant improvements in survival, functional status, and combined function and survival.
2. Long-term CNM-Au8 treatmentdemonstrated substantial survival benefits compared to matched cont...
👀👀
plz do something about how ur system calculate RS value...
No comment yet